Mary Hatch, PhD

Dr. Hatch is an Associate Professor at the Addictions, Drug & Alcohol Institute (ADAI), Department of Psychiatry & Behavioral Sciences, UW School of Medicine. Her research interests are in the development and testing of behavioral and pharmacologic interventions for substance use disorders and HIV prevention. In particular, her work has focused on the intersection of substance use and HIV-related sex and drug risk behaviors from both the consumer and workforce perspectives, and on implementation factors that affect uptake of interventions. She has held multiple and varied roles in research projects since 1994, and has long-standing experience developing, implementing, and overseeing large-scale multi-site clinical trials with community treatment providers. In addition to her work at the University of Washington, Dr. Hatch is a licensed clinical psychologist at UWMC Outpatient Psychiatry Clinic. Her clinical work specializes in the treatment of drug and alcohol addictions and co-occurring depression, anxiety and trauma.

Education

Psychology Fellow, Center for Excellence in Substance Abuse Treatment, VA Puget Sound Healthcare System-Seattle Division
Psychology Intern, VA Puget Sound Healthcare System-Seattle Division
PhD, Department of Psychology, University of Nebraska-Lincoln

Department Affiliations

Other Affiliations

NIDA Summer Research Internship Program

UW Medical Student Addiction Research Program (MedStAR)

Recent Publications

Supporting Unhealthy Substance use care Through a whole person Approach and user centered INtegration into primary care (SUSTAIN): Study protocol for a type 2 hybrid effectiveness-implementation trial.
(2025 Jan 25)
J Subst Use Addict Treat 171(): 209626
Simon CB, Britz JB, Keiser B, Brooks EM, Krist AH, Franko N, Webel B, Hatch MA, Tsui JI, Stephens KA, Tong ST

HIV Prevention in Syringe Service Programs Since the Start of COVID-19: Where Do We Go From Here?
(2025 Jan 15)
Curr HIV/AIDS Rep 22(1): 13
Hatch MA, Ertl M, Closs D, Keeshin S, Feinberg J, Orozco K, Tross S

Willingness to Use Oral and Long-Acting Injectable PrEP in Substance-Using Men who have Sex with Men (SU-MSM) in High HIV Incidence Southern U.S. Cities: A NIDA Clinical Trials Network Study.
(2024 Dec 30)
AIDS Behav
Tross S, Laschober TC, Paschen-Wolff M, Ertl M, Nelson CM, Wright L, Lancaster C, Feaster DJ, Monger M, Toal P, Fegley JP, Meche D, Hankey C, Woodhouse C, Spector A, Dresser L, Moran L, Jelstrom E, Haynes L, Shoptaw S, Hatch MA

Factors associated with PrEP awareness and use among men who have sex with men who use drugs in the Southern United States.
(2025 Jan)
AIDS Care 37(1): 21-32
Paschen-Wolff MM, Tross S, Mindy Nelson C, Hatch MA, Meche D, Ertl MM, Wright L, Laschober TC

The Impact of the COVID-19 Pandemic on Patient Disparities in Long-Term Opioid Therapy.
(2024 Mar-Apr)
J Am Board Fam Med 37(2): 290-294
Tong ST, Zheng Z, Prado MG, West II, LeMaster JW, Hatch MA, Szabo LS, Anastas TM, Ma KPK, Stephens KA

Show complete publication list »
Edit Profile